Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides
Open Access
- 12 April 2002
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1587 (2-3) , 287-295
- https://doi.org/10.1016/s0925-4439(02)00091-1
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Bicyclic nucleoside inhibitors of Varicella-Zoster virus (VZV)Bioorganic & Medicinal Chemistry Letters, 2001
- The structures of thymidine kinase fromHerpes simplexvirus type 1 in complex with substrates and a substrate analogueProtein Science, 1997
- The three‐dimensional structure of thymidine kinase from Herpes simplex virus type 1FEBS Letters, 1995
- Steric fixation of bromovinyluracil: Synthesis of furo[2,3‐d]pyrimidine nucleosidesJournal of Heterocyclic Chemistry, 1995
- Synthesis and properties of 5‐(1,2‐dihaloethyl)‐2′‐deoxyuridines and related analoguesJournal of Heterocyclic Chemistry, 1991
- Evolution of herpesvirus thymidine kinases from cellular deoxycytidine kinaseJournal of General Virology, 1991
- Targets for the Antiviral Activity of Pyrimidine and Purine Nucleoside AnaloguesNucleosides and Nucleotides, 1987
- Nucleic acid related compounds. 39. Efficient conversion of 5-iodo to 5-alkynyl and derived 5-substituted uracil bases and nucleosidesThe Journal of Organic Chemistry, 1983
- Inhibition of thymidylate synthetase by 5-alkynyl-2'-deoxyuridylatesJournal of Medicinal Chemistry, 1981
- Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex VirusThe Journal of Infectious Diseases, 1980